PostersISBT2006PostersTOPIC 01.5The posters areon display fromMonday - ThursdayTOPIC 01.6The posters areon display fromMonday - ThursdayP-096 RESULTS OF NAT- AND ANTIBODY-SCREENING FOR WEST NILEVIRUS IN GERMANY AND AUSTRIAM.K. Hourfar, C. Pfleiderer, J. Eckert, A. Themann, E. Seifried, M. Nuebling, M. Schmidt(German Red Cross, Institute Frankfurt, Frankfurt, Germany)P-104 INACTIVATION OF CHIKUNGUNYA VIRUS IN PLASMA AND PLATELETSUSING HELINX TECHNOLOGY, AS UTILIZED IN THE INTERCEPT BLOODSYSTEML. Corash, L. Sawyer, K. Dupuis, A. Sampson-Johannes, T. Dubensky, D.L. Vanlandingham,K. Tsetsarkin, S. Higgs (Cerus Corporation, Concord, United States of America)P-097 PROTECTIVE ROLE OF NATURAL ANTIBODIES IN WNV INFECTION:IN VITRO INFECTIVITY OF WNV ID NAT REACTIVE PLASMAS CONTAININGSPECIFIC ANTIBODIES (IGM AND/OR IGG)M. Rios, S. Daniel, S.L. Stramer, S. Caglioti, O. Wood, I.K. Hewlett (CBER/FDA, Bethesda,United States of America)Topic 01.6.<strong>Blood</strong> Safety - TTD - Nucleic Acid Amplification Technology (NAT)P-098 YIELD OF MINIPOOL AND INDIVIDUAL DONATION NUCLEIC ACIDAMPLIFICATION TESTING FOR WEST NILE VIRUS RNA IN UNITED STATESBLOOD DONORS, 2003-2005L. Stramer, G.A. Foster, J.P. Brodsky, S.G. Caglioti, D.M. Strong (American Red Cross,Gaithersburg, United States of America)P-105 THE CONTRIBUTION OF NUCLEID ACID TESTING (NAT) IN BLOODTRANSFUSION SAFETY. DETECTION OF FOUR NAT HBV DNA POSITIVE,HBS AG NEGATIVE IN SINGLE BLOOD DONATIONSC. Politi, V. Dimitra, L. Kavallierou, V. Triantaltillou, (G.Gennimatas Hospital, Athens, Greece)80Topic 01.5.<strong>Blood</strong> Safety - TTD - Emerging PathogensP-106 IMPLEMENTATION OF A POST-DONATION TRIPLEX HIV/HBV/HCVNAT IN A TEACHING HOSPITAL TRANSFUSION MEDICINE UNIT INKUMASI, GHANAJ.P. Allain, S. Owusu-O<strong>for</strong>i, G. Bedu-Addo, D. Candotti, A. Nsiah-Asare, F. Sarkodie(University of Cambridge, Cambridge, United Kingdom)81P-100 IMMUNOGLOBULIN G ANTIBODIES AGAINST ENVIRONMENTALMOULDS IN A NORWEGIAN HEALTHY POPULATION SHOWS A BIMODALDISTRIBUTION FOR ASPERGILLUS VERSICOLORG. Hetland, B. Rydjord, V. Svenningsen, H.G. Wiker (Ulleval University Hospital, Oslo, Norway)P-107 PREVALENCE OF HCV AND HGV INFECTION AMONG THALASSEMICS,HEMOPHILICS, AND HEMODIALYSIS PATIENTS WITH CHRONIC HEPATITISS. Amini Kafi-abad, A. Talebian, S. Samiee, F. Ranjbar Kermani, M.M. Moghtadaie,F. Ferdowsian, N.P. Pasandideh, Z. Ataie, M. Kavari, A. Gharehbaghian (Research Center ofIranian <strong>Blood</strong> <strong>Transfusion</strong>, Tehran, Iran)P-101 THE NEEDS OF LOOK BACK ON SCREENING OF HUMAN T CELLLYMPHOTROPIC VIRUS TYPE 1 AND 11 (HTLV I / II) AMONG BLOODDONORS IN SAUDI ARABIAS. ibrahim Hindawi, G.A. Damanhouri, I.S. Kawashti, I. Felemban, M. Alshawa, M. Khanbashi(KAUH, Jeddah, Saudi Arabia)P-108 HEAD TO HEAD COMPARISON OF TWO NEW AUTOMATED NATSYSTEMS CHIRON PROCLEIX TIGRIS SYSTEM VS ROCHE COBAS S 201A. Assal, V. Barlet, C. Cornillot, M. Deschazeaux, I. Dupont, P. Gallian, C. Guitton, P. Morel,G. Andreu (EFS Centre Atlantique, Tours, France)P-102 TRANSFUSION-TRANSMITTED HUMAN PARVOVIRUS B19 INFECTIONIN A THALASSAEMIA PATIENTSM. Mahmoodian Shooshtari, M. Nabi Foroghi, Z. Sharifi (Research Center of IBTO, Tehran, Iran)P-109 WINDOW PERIOD OF HIV INFECTION IN A REPEAT BLOOD DONORL. Barea, R. Gonzalez, J.l. Bueno, L. Muñoz, A. Garcia, E. Castro (Centro de Transfusión CruzRoja Española, Madrid, Spain)P-103 IN VITRO EVALUATION OF CELL-MEDIATED IMMUNITY TO EPSTEINBARR VIRUSM. Mahmoodian Shooshtari, M. Bani Talebi Dehkordi, Z. Sharifi (Research Center of IBTO,Tehran, Iran)P-110 SEROLOGICAL AND MOLECULAR CHARACTERISTICS OF HBV DNAPOSITIVE/ HBSAG NEGATIVE BLOOD DONORSE. Brojer, M. Letowska, G. Liszewski, P. Grabarczyk, M. Mikulska (Institute of Haematologyand <strong>Blood</strong> <strong>Transfusion</strong>, Warsaw, Poland)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT
PostersISBT2006PostersTOPIC 01.6TOPIC 01.6P-111 HIGH THROUGH-PUT, INDIVIDUAL DONOR TESTING (IDT) USING THEPROCLEIX TIGRIS SYSTEM: A 5-MONTH EXPERIENCER. Cable (Western Province <strong>Blood</strong> <strong>Transfusion</strong> Servi, Cape Town, South Africa)P-119 PERFORMANCE CHARACTERISTICS OF A NEW MULTIPLEX NATSCREENING TEST FOR HBV, HCV AND HIV: THE COBAS TAQSCREEN MPXTEST ON THE COBAS S 201 SYSTEMS. Herman, Y. Ohhashi, E. Kyger, H. Halait, M. Wiedmann, M. Zauke, L. Pietrelli(Roche Molecular Systems, Inc., Pleasanton, United States of America)P-112 INTERPRETATION OF HBV NAT RESULTS IN HEALTHY SUBJECTSG. Cambie, A. Degiuli, S. Conca, E. Parabiaghi, L. Vignati, M.L. Nardella, M. D'Agostino,F. D'Agostino (Azienda Ospedaliera di Lodi, Lodi, Italy)P-113 ACUTE PHASE AND OCCULT HBV INFECTIONS WITH MULTIPLEMUTATIONS IN THE SURFACE ANTIGEN “A” DETERMINANT DETECTEDBY HBV/HCV/HIV-1 TMA SCREENING OF SPANISH BLOOD DONORSE. Castro, P. Torres, R. González, A. Ontañón, L. González Ponte, M. Sedeño,J.M. Echevarría, M. Koppelman, H. Zaaijer, J.M. Hernández, N. Lelie (Centro de TransfusiónCruz Roja Española, Madrid, Spain)P-120 EXPERIENCE OF A LARGE GERMAN RED CROSS BLOOD DONORSERVICE WITH NAT-TESTING: RESULTS OF SCREENING MORE THAN 9MILLION BLOOD DONATIONS FOR HIV-1, HCV AND HBVM.K. Hourfar, W.K. Roth, A. Themann, K. Gubbe, U. Mayr-Wohlfart, E. Seifried, M. Schmidt(German Red Cross, Institute Frankfurt, Frankfurt, Germany)P-121 SIMULTANEOUS SCREENING FOR HCV, HIV-1 AND HBV IN BLOODDONATIONS WITH THE FULLY AUTOMATED SYSTEMP. Iudicone, M. Miceli, A. Agresti, M. Palange, A. Di Lorenzo, S. Berardini, C. Amedeo,A. Tudisco, R. Colaceci, E. Mannella (A.O. S.Camillo-Forlanini, Rome, Italy)82P-114 ANALYTICAL PERFORMANCE OF PROCLEIX DUPLEX AND TRIPLEXTMA ASSAYS IN AN HISTORICAL PROFICIENCY PROGRAMMEA. van Drimmelen, P.N. Lelie, D. Jardine (AcroMetrix Europe, Alkmaar, Netherlands)P-115 REAL- TIME PCR ASSAY BY LIGHT CYCLER FOR THE DETECTIONOF PLASMODIUM SPECIESS. Dupont, A. Berry, J.M. Fondere, C. Segarra, C. Maugard, T. Levayer (EFS PyrénéesMediterranée, Montpellier, France)P-116 AN HCV SEROCONVERSION DETECTED USING A NAT TESTPROCEDURE DURING SCREENIG OF BLOOD AND BLOOD COMPONENTSIN A DONOR POPULATION IN ITALIAN CAMPANIA REGIONC. de Felice, C. de Felice, F. Morelli, A. Miscioscia, D. Ametrano, C. Fasulo, S. Guardascione,M. Macrì (A.O.R.N. A. Cardarelli, Naples, Italy)P-122 QUALITY CONTROL PROGRAMME FOR NUCLEIC ACID SCREENINGIN BLOOD SERVICE LABORATORIESK. Jardine, B.R.J. Dent, T. Pham, W. Dimech, E.M. Dax (National Serology ReferenceLaboratory, Fitzroy, Australia)P-123 EVALUATION OF THE COBAS TAQSCREEN MULTIPLEX TEST ANDS201 AUTOMATED NAT PLATFORM IN THE SCOTTISH NATIONAL BLOODTRANSFUSION SERVICE.L. Jarvis, A. Cleland, T. Duns<strong>for</strong>d, K. Mulligan, J. Petrik (SNBTS, Edinburgh, United Kingdom)P-124 HBV AND HCV INFECTED BLOOD DONATIONS INTERDICTED BYINDIVIDUAL DONATION NUCLEIC ACID TESTING (ID-NAT) IN LITHUANIAV. Kalibatas, J. Irzikeviciene, N. Lelie (National <strong>Blood</strong> Centre, Vilnius, Lithuania)83P-117 INDIVIDUAL HEPATITIS B VIRUS NUCLEIC ACID TESTING (HBV-NAT)ON 61.825 BLOOD DONATIONS IN MADRID, SPAINR. Gonzalez, J.M. Echevarría, A. Avellon, L. Barea, J.L. Bueno, E. Castro (Centro deTransfusión Cruz Roja Española, Madrid, Spain)P-125 ANALYTICAL AND CLINICAL PERFORMANCE OF THE PROCLEIXULTRIO HIV-1/HCV/HBV ASSAY IN LOW VIRAL LOAD SAMPLESA. Katsoulidou, Z. Moschidis, V. Sypsa, M. Chini, G. Papatheodoridis, N. Tassopoulos,K. Mimidis, A. Karafoulidou, A. Hatzakis (Athens University Medical School, Athens, Greece)P-118 EVALUATION OF SINGLE NAT IN A NATIONAL BLOOD SERVICEA. Gottreich, B. Cohen, L. Shvartz, V. Arad, O. Frenkel, V.B. Yahalom, E. Shinar (Magen DavidAdom, Tel-hasomer, Israel)P-126 THE IMPORTANCE OF IMPLEMENTING THE HBV DNA SCREENING USINGNAT TESTING FOR TRANSFUSIONAL VALIDATION IN A HIGH HBV RISK AREAM. Manca, A. Spano, R. Occhineri, F. Fadda, P. Manchia, F. Lumbau, P. Murgia, G. Tala,G. Sanna, G. Cossu (AUSL 1 - Sassari, Sassari, Italy)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT
- Page 24 and 25: XXIX th International Congressof th
- Page 26 and 27: ISBT2006WORDS OF WELCOME5It is with
- Page 28 and 29: ISBT20068ORGANISATION - COMMITTEESO
- Page 30 and 31: Programme per DayISBT2006Programme
- Page 32 and 33: ISBT2006Programme per DayTHURSDAY,
- Page 34 and 35: Sunday, 3 SeptemberISBT2006Sunday,
- Page 36 and 37: Sunday, 3 SeptemberISBT2006Monday,
- Page 38 and 39: Monday, 4 SeptemberISBT2006Monday,
- Page 40 and 41: Monday, 4 SeptemberISBT2006Monday,
- Page 42 and 43: Monday, 4 SeptemberISBT2006Monday,
- Page 44 and 45: Monday, 4 SeptemberISBT2006Tuesday,
- Page 46 and 47: Tuesday, September 5ISBT2006Wednesd
- Page 48 and 49: Wednesday, 6 SeptemberISBT2006Wedne
- Page 50 and 51: Wednesday, 6 SeptemberISBT2006Wedne
- Page 52 and 53: Wednesday, 6 SeptemberISBT2006Wedne
- Page 54 and 55: Wednesday, 6 SeptemberISBT2006Thurs
- Page 56 and 57: Thursday, 7 SeptemberISBT2006Thursd
- Page 58 and 59: PostersISBT2006PostersTOPIC 01.1The
- Page 60 and 61: PostersISBT2006PostersTOPIC 01.2TOP
- Page 62 and 63: PostersISBT2006PostersTOPIC 01.2TOP
- Page 66 and 67: PostersISBT2006PostersTOPIC 01.6TOP
- Page 68 and 69: PostersISBT2006PostersTOPIC 01.8The
- Page 70 and 71: PostersISBT2006PostersTOPIC 02.1TOP
- Page 72 and 73: PostersISBT2006PostersTOPIC 02.1TOP
- Page 74 and 75: PostersISBT2006PostersTOPIC 02.1TOP
- Page 76 and 77: PostersISBT2006PostersTOPIC 02.2TOP
- Page 78 and 79: PostersISBT2006PostersTOPIC 02.4TOP
- Page 80 and 81: PostersISBT2006PostersTOPIC 03.2The
- Page 82 and 83: PostersISBT2006PostersTOPIC 04.3The
- Page 84 and 85: PostersISBT2006PostersTOPIC 05.2The
- Page 86 and 87: PostersISBT2006PostersTOPIC 05.2TOP
- Page 88 and 89: PostersISBT2006PostersTOPIC 07.2The
- Page 90 and 91: PostersISBT2006PostersTOPIC 08.1-3T
- Page 92 and 93: PostersISBT2006PostersTOPIC 09.2TOP
- Page 94 and 95: PostersISBT2006PostersTOPIC 10.1TOP
- Page 96 and 97: PostersISBT2006PostersTOPIC 11.1The
- Page 98 and 99: PostersISBT2006PostersTOPIC 11.4The
- Page 100 and 101: PostersISBT2006PostersTOPIC 13.0TOP
- Page 102 and 103: PostersISBT2006PostersTOPIC 15.0TOP
- Page 104 and 105: ISBT Business MeetingsISBT2006Key I
- Page 106 and 107: Key InformationISBT2006Key Informat
- Page 108 and 109: Scientific InformationISBT2006Scien
- Page 110 and 111: Registration InformationISBT2006Soc
- Page 112 and 113: ISBT2006FLOORPLANGROUND FLOORFLOORP
- Page 114 and 115:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 116 and 117:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 118 and 119:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 120 and 121:
ISBT2006LIST OF EXHIBITORSin terms
- Page 122 and 123:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 124 and 125:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 126 and 127:
ISBT2006LIST OF EXHIBITORS59 Cape C
- Page 128 and 129:
ISBT2006MAP OF CAPE TOWNSPEAKERS IN
- Page 130 and 131:
International Society ofBlood Trans
- Page 132:
ISBT2006NOTES216INTERNATIONAL SOCIE